IBDEI0HI ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7882,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,7882,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,7883,0)
 ;;=M34.81^^39^391^315
 ;;^UTILITY(U,$J,358.3,7883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7883,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,7883,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,7883,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,7884,0)
 ;;=M34.82^^39^391^316
 ;;^UTILITY(U,$J,358.3,7884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7884,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,7884,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,7884,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,7885,0)
 ;;=M34.83^^39^391^317
 ;;^UTILITY(U,$J,358.3,7885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7885,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,7885,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,7885,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,7886,0)
 ;;=M34.89^^39^391^314
 ;;^UTILITY(U,$J,358.3,7886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7886,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,7886,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,7886,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,7887,0)
 ;;=M34.9^^39^391^318
 ;;^UTILITY(U,$J,358.3,7887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7887,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,7887,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,7887,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,7888,0)
 ;;=R21.^^39^391^297
 ;;^UTILITY(U,$J,358.3,7888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7888,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,7888,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,7888,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,7889,0)
 ;;=R23.3^^39^391^309
 ;;^UTILITY(U,$J,358.3,7889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7889,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,7889,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,7889,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,7890,0)
 ;;=L03.113^^39^391^114
 ;;^UTILITY(U,$J,358.3,7890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7890,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,7890,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,7890,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,7891,0)
 ;;=L03.114^^39^391^107
 ;;^UTILITY(U,$J,358.3,7891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7891,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,7891,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,7891,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,7892,0)
 ;;=L03.115^^39^391^111
 ;;^UTILITY(U,$J,358.3,7892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7892,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,7892,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,7892,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,7893,0)
 ;;=L03.116^^39^391^104
 ;;^UTILITY(U,$J,358.3,7893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7893,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
 ;;^UTILITY(U,$J,358.3,7893,1,4,0)
 ;;=4^L03.116
 ;;^UTILITY(U,$J,358.3,7893,2)
 ;;=^5133645
 ;;^UTILITY(U,$J,358.3,7894,0)
 ;;=L03.123^^39^391^28
 ;;^UTILITY(U,$J,358.3,7894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7894,1,3,0)
 ;;=3^Acute Lymphangitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,7894,1,4,0)
 ;;=4^L03.123
 ;;^UTILITY(U,$J,358.3,7894,2)
 ;;=^5009039
 ;;^UTILITY(U,$J,358.3,7895,0)
 ;;=L03.124^^39^391^22
